Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0262471 (ENT)
 5,307 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Tumour markers are often circulating tumour-associated indicators of tumour development. As such they are not suitable for tumour screening and localization, but valuable as adjuncts for medical follow-up care of tumour patients, where their serum level alterations may anticipate the clinical detection of tumour behaviour by a lead time of 1 to 6 months before other methods. The following tumour may be controlled by established markers: endocrine tumours by NSE, calcitonin, parathormone, 5-HIAA, catecholamines/metabolites etc.; head-neck tumours: SCC, CEA; thyroid carcinoma: TG, calcitonin; lung cancer: CEA, NSE, SCC; liver cancer: AFP (PLC), CA 19-9 (cholangiocell.), CEA (secondary): biliary tract and pancreatic cancer: CA 19-9; colorectal carcinoma: CEA, CA 19-9; squamous cell carcinoma (ENT, oesophagus, anal): SCC; breast cancer: CEA and CA 15-3; ovarian cancer: CA 125 (epithelial), CA 19-9 (mucinous); germ cell tumours (ovary including trophoblastic tumours/testes): AFP and HCG; prostatic cancer: PAP and PSA; bladder cancer: TPA.
 ...
PMID:[Clinical relevance of tumor markers]. 267 6

Our ENT-Service has performed a total figure of 96 parathyroidectomies between these two dates 1990 and 2001, in 99 patients remitted diagnosed of hyperparathyroidism. 74 cases had primary hyperparathydoidism, in 22 the condition was secondary and in 3 tertiary. A series of variables pre- and postoperative of each case. Since June 2000 our Hospital has at it disposal a device for quick appraisal of parathormone rate allowing us in few minutes and with the patient still in the operating theatre, if there are hyperparathyroidal tissue still alive. The surgery done was: adenoma resection 69 cases, 23 subtotal parathyroidectomies and 4 total resections. Comparison of our results with those of other series published.
 ...
PMID:[The clinical value of PTHi in hyperparathyroidism. Our experience (1990-2001)]. 1246 26